News

News Archives: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Press Releases

December 7, 2012

BrainCells, Inc. Announces the Successful Completion of a Multiple Ascending Dose Study of BCI-838, a Group II mGluR2/3 Antagonist, and the Company’s Plans for a Proof-of-Concept Study in Patients with Treatment-Resistant Depression

February 29, 2012

BrainCells Inc. Announces the Successful Completion of the Single Ascending Dose Study with BCI-838 and the Initiation of the Multiple Ascending Dose Study

August 4, 2010

BrainCells Inc. Acquires Clinical -Stage Compound Sabcomeline From Proximagen Group

More Press Releases »

BrainCells in the News

June 1, 2010

BrainCells Reveals New BCI-540 Phase II Data

Neurotech Insights. 2010 June 1.

September 3, 2009

BrainCells Inc., Defying Convention, Suggests Novel Drug Combination Can Treat Depression

Xconomy. 2009 September 3.

March 2, 2009

BrainCells – Top 20 VC Deals of 2008

Fierce Biotech. 2009 March 2.

More News Items »